|
|
 | | | |
- close
- close
- close
- close
Arena Pharmaceuticals (ARNA) |
Benzinga
Jun 11
Comment
In a report published on Tuesday, Piper Jaffray analyst Edward A. Tenthoff raised the price target on Arena Pharmaceuticals (NASDAQ: ARNA) from $9 to $12.50 and maintained a rating of Overweight on the company.
In the report, Piper Jaffray...
Market Intelligence Center
Jun 11
Comment
Arena Pharmaceuticals (NASDAQ: ARNA) closed Monday's trading session at $8.81. In the past year, the stock has hit a 52-week low of $6.70 and 52-week high of $13.50. Arena Pharmaceuticals (ARNA) stock has been showing support around $8.63 and...
Benzinga
Jun 7
Comment
Arena Pharmaceuticals (NASDAQ: ARNA) reported today on the launch of BELVIQ (pronounced BEL-VEEK) in the United States. BELVIQ will be available to patients by prescription in US pharmacies beginning June 11. Eisai Inc. is responsible for the...
StreetInsider.com
Jun 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Arena+Pharma+%28ARNA%29+BELVIQ+Available+in+U.S.+on+June+11th/8399068.html for the full story.
Market Intelligence Center
Jun 4
Comment
Arena Pharmaceuticals (NASDAQ: ARNA) closed Monday's trading session at $8.88. In the past year, the stock has hit a 52-week low of $6.15 and 52-week high of $13.50. Arena Pharmaceuticals (ARNA) stock has been showing support around $8.61 and...
Forbes
May 8
Comment
Over the past 24 hours, two developments finally occurred to suggest overweight consumers will soon have an expanding choice of prescription diet pill options. First, Arena Pharmaceuticals disclosed that the US Drug Enforcement Agency has listed...
StreetInsider.com
May 7
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Arena+%28ARNA%29+Confirms+BELVIQ+Will+Soon+Be+Available+for+Sale+in+the+U.S./8313240.html for the full story.
Benzinga
May 7
Comment
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the Office of the Federal Register filed for public
inspection the US Drug Enforcement Administration's (DEA) final rule placing
BELVIQ ^ (pronounced BEL-VEEK) into Schedule IV of...
StreetInsider.com
May 7
Comment
The following is a list of notable articles to help get you through the lunch hour:
Nokia (NOK) Holders Get Vocal About Failing Windows Phone; Elop Firm on Decision -> Read this!
Deutsche Bank Stubborn With Low-Ball $35 Tesla (TSLA) Price...
TheStreet.com
May 7
Comment
SAN DIEGO (TheStreet) -- Areniacs rejoice! The DEA has finally published the rule establishing Arena Pharmaceuticals' weight-loss pill Belviq as a Schedule IV drug and allowing the commercial launch to begin in 30 days.
Arena shorts rejoice!...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
